Imexpharm Corporation (HOSE:IMP)
53,600
-900 (-1.65%)
At close: Jan 20, 2026
Imexpharm Company Description
Imexpharm Corporation operates as a pharmaceutical company in Vietnam.
The company’s products include injectable antibiotics, oral antibiotics, cardiovascular, ophthalmology, musculoskeletal system, analgesic - anti-inflammatory - antipyretics, respiratory system, antihistamines and anti-allergy, central nervous system, digestive system, diabetes, anti-parasitic, external drugs, vitamins and minerals, and supplements.
It is also involved in the import and export. The company was founded in 1997 and is headquartered in Cao Lãnh, Vietnam.
Imexpharm Corporation
| Country | Vietnam |
| Founded | 1997 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,452 |
| CEO | Dao Tran |
Contact Details
Address: No. 04, 30/04 Street Cao Lanh Vietnam | |
| Phone | 84 277 3851 941 |
| Website | imexpharm.com |
Stock Details
| Ticker Symbol | IMP |
| Exchange | Ho Chi Minh Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | VND |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dao Tran | Chief Executive Officer |